Anderson P M
Biochemistry. 1977 Feb 22;16(4):587-93. doi: 10.1021/bi00623a005.
The binding of ornithine and inosine 5'-monophosphate (IMP), positive allosteric effectors, and of uridine 5'-monophosphate (UMP), a negative allosteric effector, to carbamyl-phosphate synthetase from Escherichia coli was studied by the technique of equilibrium dialysis. The monomeric form of the enzyme has one binding site for each of the three allosteric ligands. The binding of UMP is inhibited by ornithine, IMP, MgATP, and ammonia (also a positive allosteric effector). Bicarbonate, L-glutamine, and adenosine 5'-triphosphate (ATP) (Mg2+ absent) had no effect on the binding of UMP. The affinity of the enzyme for UMP was increased if phosphate buffer was replaced by 2-amino-2-hydroxymethyl-1,3-propanediol (Tris) buffer. The binding of ornithine was inhibited by UMP and ammonia, enhanced by MgATP, MgADP, and IMP, and not affected by bicarbonate, L-glutamine, or ATP (Mg2+ absent). Ornithine and ammonia probably bind to the same site on the enzyme. The binding of IMP is facilitated by ornithine and ammonia, but is inhibited by MgATP or ATP, indicating that adenine nucleotides can also bind to the IMP binding site. The results of these binding studies are consistent with a scheme previously proposed in which the allosteric effectors function by stabilizing one or the other of two different conformational states of the enzyme which are in equilibrium with each other (Anderson, P.M., and Marvin, S.V. (1970), Biochemistry 9, 171). According to this scheme, binding of the substrate MgATP is greatly facilitated when the enzyme exists in the conformational state stabilized by the positive allosteric effectors.
采用平衡透析技术研究了鸟氨酸、正构象效应剂5'-单磷酸次黄苷(IMP)以及负构象效应剂5'-单磷酸尿苷(UMP)与大肠杆菌氨甲酰磷酸合成酶的结合情况。该酶的单体形式对这三种别构配体各有一个结合位点。UMP的结合受到鸟氨酸、IMP、MgATP和氨(也是一种正构象效应剂)的抑制。碳酸氢盐、L-谷氨酰胺和5'-三磷酸腺苷(ATP)(无Mg2+)对UMP的结合没有影响。如果用2-氨基-2-羟甲基-1,3-丙二醇(Tris)缓冲液代替磷酸盐缓冲液,酶对UMP的亲和力会增加。鸟氨酸的结合受到UMP和氨的抑制,受到MgATP、MgADP和IMP的增强,并且不受碳酸氢盐、L-谷氨酰胺或ATP(无Mg2+)的影响。鸟氨酸和氨可能结合在酶的同一位点上。IMP的结合受到鸟氨酸和氨的促进,但受到MgATP或ATP的抑制,这表明腺嘌呤核苷酸也可以结合到IMP结合位点上。这些结合研究的结果与先前提出的一种机制一致,即别构效应剂通过稳定酶的两种相互平衡的不同构象状态中的一种或另一种来发挥作用(安德森,P.M.,和马文,S.V.(1970年),《生物化学》9,171)。根据该机制,当酶处于由正构象效应剂稳定的构象状态时,底物MgATP的结合会大大促进。